Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman who has recently been diagnosed with triple negative breast cancer and have not yet started any treatment for it.
- Your cancer is at stage I, II, or III, or it has come back in the same local area and you have not had chemotherapy before.
- You are under 60 years old.
- You have a regular, natural menstrual cycle.
- Your doctors have planned for you to receive chemotherapy before surgery (called neoadjuvant treatment), with or without immunotherapy, targeted therapy, or hormone therapy.
- You have not received any systemic treatment (such as chemotherapy, hormone therapy, or targeted therapy) for your current cancer diagnosis.
- You are willing and able to sign a consent form agreeing to take part in the study.
Who may not be able to join:
- You are currently using hormonal contraception, or have used it in the six weeks before starting breast cancer treatment — this includes the contraceptive pill, a hormonal coil (such as a Mirena IUD), a vaginal ring (NuvaRing), an implant (Implanon), or hormonal injections.
- You are currently pregnant or breastfeeding, or if you have recently stopped hormonal contraception or breastfeeding, you have not yet had at least 2 normal menstrual periods since stopping.
- You are currently receiving ovarian function suppression to protect your fertility.
- You currently have another active cancer.
- You are going through an IVF process to freeze your eggs before starting breast cancer treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sabine Linn, MD, Antoni van Leeuwenhoek
Phone: +31205129111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
pCR rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.